Women have lower mortality than men at one year after TAVR

February 24, 2016

(HealthDay)—For patients undergoing transcatheter aortic valve replacement (TAVR), women have lower mortality than men at one year, according to a study published online Feb. 23 in the Annals of Internal Medicine.

Susheel Kodali, M.D., from the Columbia University Medical Center in New York City, and colleagues examined sex-specific differences in patients undergoing TAVR in the Placement of Aortic Transcatheter Valves (PARTNER) trial. Data were included for 1,220 and 1,339 men who were considered high-risk and inoperable.

The researchers found that women had lower rates of hyperlipidemia, diabetes, smoking, and renal disease at baseline, but higher Society of Thoracic Surgeons Predicted Risk of Mortality scores (11.9 versus 11.1 percent; P < 0.001). Women had more vascular complications (P < 0.001) and major bleeding (P = 0.012) after TAVR, but less frequent moderate and severe paravalvular regurgitation (P < 0.001). The unadjusted all-cause rate and stroke incidence at 30 days were similar (P = 0.52 and 0.28, respectively). All-cause mortality was significantly lower for women than men at one year (hazard ratio, 0.72; 95 percent confidence interval, 0.61 to 0.85).

"Sex-specific risk in TAVR is the opposite of that in surgical , for which female sex has been shown to be independently associated with an adverse prognosis," the authors write.

Several authors disclosed financial ties to pharmaceutical and medical device companies, including Edwards Lifesciences, which funded the PARTNER trial.

Explore further: HRQoL outcomes not improving for transapical TAVR

More information: Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Related Stories

HRQoL outcomes not improving for transapical TAVR

June 17, 2015
(HealthDay)—Health-related quality of life (HRQoL) outcomes have not improved for patients undergoing transapical transcatheter aortic valve replacement (TA-TAVR), according to research published online June 9 in Circulation: ...

Favorable one-year clinical outcomes for catheter-based aortic valve replacement with latest generation of device

October 15, 2015
Penn Medicine has performed more than 1,200 Transcatheter Aortic Valve Replacements (TAVR) on patients with severe aortic stenosis. Today, at the Transcatheter Cardiac Therapeutics conference in San Francisco, Howard C. Herrmann, ...

Study examines outcomes for patients one year after transcatheter aortic valve replacement

March 10, 2015
In an analysis of outcomes of about 12,000 patients who underwent transcatheter aortic valve replacement, death rate after one year was nearly one in four; of those alive at 12 months, almost half had not been rehospitalized ...

Two-year results of the CoreValve US Pivotal trial reported at TCT 2014

September 15, 2014
In extended follow-up from a clinical trial, a self-expanding transcatheter aortic valve was shown to have low rates of all-cause mortality and major stroke. Findings were reported today at the 26th annual Transcatheter Cardiovascular ...

Results of PARTNER I trial reported at TCT 2014

September 15, 2014
New data from a landmark clinical trial found that after five years, transcatheter aortic valve replacement (TAVR) demonstrated a persistent mortality benefit, improved functional status, and resulted in a lower rate of repeat ...

Transcatheter aortic valve replacement is safe, effective for very elderly patients

September 8, 2015
Select patients age 90 years and older with aortic stenosis (AS) can benefit from a relatively new, minimally invasive surgery for aortic valve replacement, according to an article in the September 2015 issue of The Annals ...

Recommended for you

Innovative triple pill significantly lowers blood pressure, study finds

August 14, 2018
A new low dose three in one pill to treat hypertension could transform the way high blood pressure is treated around the world.

Drug repurposing study sheds light on heart disease risk

August 14, 2018
A team led by researchers at Brigham and Women's Hospital has developed a computational technique to reveal the unknown side effects—both good and bad—of hundreds of drugs. That knowledge could help pharmacologists discover ...

Rethinking the stroke rule 'time is brain'

August 13, 2018
In 1993, neurologist Camilo R. Gomez, MD, coined a phrase that for a quarter century has been a fundamental rule of stroke care: "Time is brain!"

High oxidative stress hampers males' production of powerful blood vessel dilator

August 13, 2018
Higher levels of oxidative stress in males results in lower levels of a cofactor needed to make the powerful blood vessel dilator nitric oxide, researchers report.

Epigenetic reprogramming of human hearts found in congestive heart failure

August 9, 2018
Congestive heart failure is a terminal disease that affects nearly 6 million Americans. Yet its management is limited to symptomatic treatments because the causal mechanisms of congestive heart failure—including its most ...

Older adults who get physical can lower their heart disease risk

August 8, 2018
Adults in their early 60s, who spend less time sitting and more time engaged in light to vigorous physical activity, benefit with healthier levels of heart and vessel disease markers, according to new research in Journal ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.